VIRACTA THERAPEUTICS INC's ticker is VIRX and the CUSIP is 92765F108. A total of 64 filers reported holding VIRACTA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $23,678 | +6.0% | 16,793 | +9.8% | 0.00% | – |
Q4 2022 | $22,338 | -94.8% | 15,300 | -84.7% | 0.00% | – |
Q3 2022 | $427,000 | -7.0% | 99,900 | -15.6% | 0.00% | – |
Q2 2022 | $459,000 | -15.3% | 118,400 | +4.0% | 0.00% | – |
Q1 2022 | $542,000 | +13.4% | 113,800 | -13.2% | 0.00% | – |
Q4 2021 | $478,000 | +41.0% | 131,116 | +210.0% | 0.00% | – |
Q3 2021 | $339,000 | -60.5% | 42,300 | -44.2% | 0.00% | – |
Q2 2021 | $859,000 | -10.7% | 75,803 | -27.1% | 0.00% | – |
Q1 2021 | $962,000 | – | 104,011 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 831,625 | $7,693,000 | 1.42% |
BVF INC/IL | 3,094,174 | $28,621,000 | 1.07% |
SECTORAL ASSET MANAGEMENT INC | 647,556 | $5,990,000 | 0.45% |
Logos Global Management LP | 470,000 | $4,348,000 | 0.42% |
AlphaCentric Advisors LLC | 92,402 | $855,000 | 0.29% |
SILVERARC CAPITAL MANAGEMENT, LLC | 28,570 | $264,000 | 0.14% |
Opaleye Management Inc. | 103,600 | $958,000 | 0.14% |
Monashee Investment Management LLC | 84,802 | $784,000 | 0.12% |
KETTLE HILL CAPITAL MANAGEMENT, LLC | 93,900 | $869,000 | 0.08% |
Ikarian Capital, LLC | 155,599 | $1,439,000 | 0.05% |